Evaluation of oprD Gene Expression in Carbapenem-Resistant Pseudomonas aeruginosa Strains Isolated From Severe Burn Patients With Secondary Infection

Creative Commons License
Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Evaluation of oprD Gene Expression in Carbapenem-Resistant Pseudomonas aeruginosa Strains Isolated From Severe Burn Patients With Secondary Infection


Akram Azimi 1
,
Taghi Naserpour 1 , *
,
Fariba Bazmi 1
,
Amir Peymani 1
,
Masumeh Aslanimehr 1
and
Saman Saadat 1

Authors Information

1 Department of Microbiology, Medical School, Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, IR Iran
Article information
  • Biotechnology and Health Sciences: August 01, 2015, 2 (3); e30748
  • Published Online: August 24, 2015
  • Article Type: Research Article
  • Received: June 13, 2015
  • Revised: June 30, 2015
  • Accepted: July 7, 2015
  • DOI: 10.17795/bhs30748

To Cite: Azimi A, Naserpour T, Bazmi F, Peymani A, Aslanimehr M, et al. Evaluation of oprD Gene Expression in Carbapenem-Resistant Pseudomonas aeruginosa Strains Isolated From Severe Burn Patients With Secondary Infection, Biotech Health Sci. 2015 ;2(3):e30748. doi: 10.17795/bhs30748.

Abstract
Copyright: Copyright © 0, Biotechnology and Health Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Jabalameli F, Mirsalehian A, Sotoudeh N, Jabalameli L, Aligholi M, Khoramian B, et al. Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran. Burns. 2011; 37(7): 1202-7[DOI]
  • 2. Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns. 2010; 36(1): 70-4[DOI][PubMed]
  • 3. Aoki S, Hirakata Y, Kondoh A, Gotoh N, Yanagihara K, Miyazaki Y, et al. Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo. Antimicrob Agents Chemother. 2004; 48(5): 1876-8[PubMed]
  • 4. Siarkou VI, Vitti D, Protonotariou E, Ikonomidis A, Sofianou D. Molecular epidemiology of outbreak-related pseudomonas aeruginosa strains carrying the novel variant blaVIM-17 metallo-beta-lactamase gene. Antimicrob Agents Chemother. 2009; 53(4): 1325-30[DOI][PubMed]
  • 5. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M, et al. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol. 2007; 45(3): 979-89[DOI][PubMed]
  • 6. Joklik W, Willet HP, Amos DB, Wilfert CM. Zinsser Microbiology. 2002;
  • 7. Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Am J Infect Control. 2006; 34(4): 188-92[DOI][PubMed]
  • 8. Lagatolla C, Edalucci E, Dolzani L, Riccio ML, De Luca F, Medessi E, et al. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity. J Clin Microbiol. 2006; 44(7): 2348-53[DOI][PubMed]
  • 9. Keen E3, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, et al. Incidence and bacteriology of burn infections at a military burn center. Burns. 2010; 36(4): 461-8[DOI][PubMed]
  • 10. Lim KT, Yasin RM, Yeo CC, Puthucheary SD, Balan G, Maning N, et al. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia. J Microbiol Immunol Infect. 2009; 42(3): 197-209[PubMed]
  • 11. Huang YT, Chang SC, Lauderdale TL, Yang AJ, Wang JT. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan. Diagn Microbiol Infect Dis. 2007; 59(2): 211-6[DOI][PubMed]
  • 12. Laupland KB, Parkins MD, Church DL, Gregson DB, Louie TJ, Conly JM, et al. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains. J Infect Dis. 2005; 192(9): 1606-12[DOI][PubMed]
  • 13. Rizek C, Fu L, dos Santos L, Leite G, Ramos J, Rossi F, et al. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance. Ann Clin Microbiol Antimicrob. 2014; 13(1): 43[DOI]
  • 14. Tam VH, Chang KT, Abdelraouf K, Brioso CG, Ameka M, McCaskey LA, et al. Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2010; 54(3): 1160-4[DOI][PubMed]
  • 15. Zavascki AP, Carvalhaes CG, Picao RC, Gales AC. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther. 2010; 8(1): 71-93[DOI][PubMed]
  • 16. Li H, Luo YF, Williams BJ, Blackwell TS, Xie CM. Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies. Int J Med Microbiol. 2012; 302(2): 63-8[DOI][PubMed]
  • 17. Quale J, Bratu S, Gupta J, Landman D. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2006; 50(5): 1633-41[DOI][PubMed]
  • 18. Hammami S, Ghozzi R, Burghoffer B, Arlet G, Redjeb S. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Pathol Biol (Paris). 2009; 57(7-8): 530-5[DOI][PubMed]
  • 19. Naenna P, Noisumdaeng P, Pongpech P, Tribuddharat C. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates. Southeast Asian J Trop Med Public Health. 2010; 41(3): 614-24[PubMed]
  • 20. Biswas S, Mohammad MM, Patel DR, Movileanu L, van den Berg B. Structural insight into OprD substrate specificity. Nat Struct Mol Biol. 2007; 14(11): 1108-9[DOI][PubMed]
  • 21. Trias J, Nikaido H. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1990; 34(1): 52-7[PubMed]
  • 22. Dumas JL, van Delden C, Perron K, Kohler T. Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol Lett. 2006; 254(2): 217-25[DOI][PubMed]
  • 23. Poissy J, Senneville E. New antibiotics for severe ICU-aquired bacterial infections. Infect Disord Drug Targets. 2011; 11(4): 401-12[PubMed]
  • 24. El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. APMIS. 2005; 113(3): 187-96[DOI][PubMed]
  • 25. Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Int J Antimicrob Agents. 2010; 35(5): 486-91[DOI][PubMed]
  • 26. Riera E, Cabot G, Mulet X, Garcia-Castillo M, del Campo R, Juan C, et al. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J Antimicrob Chemother. 2011; 66(9): 2022-7[DOI][PubMed]
  • 27. Rodriguez-Martinez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009; 53(11): 4783-8[DOI][PubMed]
  • 28. Pirnay JP, De Vos D, Mossialos D, Vanderkelen A, Cornelis P, Zizi M. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ Microbiol. 2002; 4(12): 872-82[PubMed]